-
Test Announces
Test Announces
Share
SAN FRANCISCO--(BUSINESS WIRE)--About Test
About Test
Test is a clinical-stage, test company focused on developing and commercializing novel, non-test test test. The company’s portfolio of proprietary products is designed to provide long-lasting, selective pain relief after a single local injection. Test, in Phase 2 development, is the company’s lead product candidate for postsurgical pain. Test has two additional active programs for multiple indications with significant unmet medical need: test pain and chronic test pain. For more information, please visit the company’s website at: www.Test.com.
Contacts
For More Information:
Test
More News From Test
Test Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Test Therapeutics Incorporated (NASDAQ:TEST) today announced it will report third quarter financial results and provide a corporate update on October 30, 2024. The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Conference Call Information Participants must register in advance of the conference call by clicking here. Upon registering, each participant will receive a dial-in number, and a unique access P...
Test
Test--(BUSINESS WIRE)--Test...
Logo Testing 51946288
SF--(BUSINESS WIRE)--Default logo and manually uploaded logo Default logo (hedgehog) is primary Copy Approval Approve with default logo (hedgehog) #1 and xmit Then cancel and change Test logo to #1...
